You are here

Zykadia

NICE nods for AbbVie in hep C and Novartis in lung cancer

Pharma Times

Sun, 12/10/17 - 09:53 am

ALK-positive non-small cell lung cancer

With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer

Fierce Pharma

Tue, 11/7/17 - 10:55 am

Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer

BioPharma Dive

Thu, 06/1/17 - 09:00 am

ALK-positive non-small cell lung cancer

Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod

Fierce Pharma

Wed, 05/31/17 - 09:32 am

non-small cell lung cancer

The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up

Endpoints

Thu, 02/23/17 - 09:23 am

ALK-positive non-small cell lung cancer

non-small cell lung cancer

Novartis's Zykadia gets positive results, faces Roche pressure

Yahoo/Reuters

Fri, 09/23/16 - 10:07 pm

non-small cell lung cancer

Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA

Endpoints

Fri, 09/23/16 - 11:47 am

non-small cell lung cancer

rheumatoid arthritis

Novartis grabs Zykadia approval in Europe, setting the stage for PD-L1 showdown

Fierce Pharma

Fri, 05/8/15 - 04:38 pm

PDL-1 inhibitors

Novartis lung cancer drug gets EU recommendation

Yahoo/Reuters

Fri, 02/27/15 - 09:09 am

Novartis says Zykadia shrank tumors in majority of patients with ALK+ NSCLC

The Fly on the Wall

Mon, 06/2/14 - 06:10 pm

non-small cell lung cancer

Meet Lung Cancer's New Enemy

Motley Fool

Sat, 05/3/14 - 11:31 am

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

The Street

Sat, 04/12/14 - 10:27 am